Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL): Flow Cytometry (FC) or Immunohistochemistry (IHC)?

被引：0
|
作者：
Amador-Ortiz, C.
Menke, D. M.
Valdez, R.
Jiang, L.
Michael, T. M.
Morice, W. G.
Jevremovic, D.
Shanafelt, T. D.
Hanson, C. A.
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin, Jacksonville, FL 32224 USA
[3] Mayo Clin, Scottsdale, AZ USA
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1355
引用
收藏
页码：322A / 322A
页数：1
相关论文
共 50 条
  • [1] Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL): Flow Cytometry (FC) or Immunohistochemistry (IHC)?
    Amador-Orliz, C.
    Menke, D. M.
    Valdez, R.
    Jiang, L.
    Michael, T. M.
    Morice, W. G.
    Jevremovic, D.
    Shanafelt, T. D.
    Hanson, C. A.
    LABORATORY INVESTIGATION, 2012, 92 : 322A - 322A
  • [2] Minimal residual disease (MRD) in hairy cell leukemia (HCL):: Comparative detection by flow cytometry (FC) and immunohistochemistry (IHC).
    Sarmiento, M
    Scolnik, M
    Narbaitz, M
    Bengió, R
    BLOOD, 1999, 94 (10) : 284A - 284A
  • [3] FLOW CYTOMETRY OR IMMUNOHISTOCHEMISTRY FOR MINIMAL RESIDUAL DISEASE DETECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA?
    Hanson, Curtis
    Amador-Ortiz, Catalina
    Timm, Michael
    Morice, William
    Jevremovic, Dragan
    Shanafelt, Tait
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2012, 34 : 51 - 52
  • [4] Recent enhancements of minimal residual disease detection by flow-cytometry in chronic lymphocytic leukemia: a study of the French CLL-MRD group
    Dahmani, Abdelmalek
    Arnoulet, Christine
    Baseggio, Lucile
    Campos, Lydia
    Chatelain, Bernard
    Debliquis, Agathe
    Drenou, Bernard
    Jacob, Marie-Christine
    Legac, Eric
    Le Garff-Tavernier, Magali
    Quiney, Claire
    Robillard, Nelly
    Solly, Francoise
    Ticchioni, Michel
    Cartron, Guillaume
    Dartigeas, Caroline
    Feugier, Pierre
    Leblond, Veronique
    Lepretre, Stephane
    Van den Neste, Eric
    Delfau-Larue, Marie-Helene
    Cymbalista, Florence
    Letestu, Remi
    LEUKEMIA & LYMPHOMA, 2015, 56 : 115 - 116
  • [5] Detection of minimal residual disease in B chronic lymphocytic leukemia (CLL)
    Magnac, C
    Sutton, L
    Cazin, B
    Laurent, C
    Binet, JL
    Merle-Béral, H
    Dighiero, G
    Maloum, K
    HEMATOLOGY AND CELL THERAPY, 1999, 41 (01) : 13 - 18
  • [6] Minimal residual disease (MRD) detection in chronic lymphocytic leukemia (CLL) via an 8 color flow cytometry panel comprising the signature gene ROR1
    Patz, Michaela
    Pentok, Barbara
    Cremer, Kathrin
    Linnartz, Stefanie
    Lilienweiss, Esther
    Kleinert, Fanni
    Hallek, Michael
    Kreuzer, Karl-Anton
    LEUKEMIA & LYMPHOMA, 2017, 58 : 93 - 94
  • [7] ROR-1 Is a Highly Discriminative Marker in Flow Cytometric Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL)
    Patz, Michaela
    Pentok, Barbara
    Cremer, Kathrin
    Linnartz, Stefanie
    Lilienweiss, Esther
    Kleinert, Fanni
    Hallek, Michael
    Kreuzer, Karl-Anton
    BLOOD, 2016, 128 (22)
  • [8] Validation of minimal residual disease: Flow cytometry method for residual disease monitoring in Chronic Lymphocytic Leukemia
    Tangri, Shabnam
    Estrellado, Annalee
    Ranuio, Julie
    Romeo, Elisa
    Lawson, Jonny
    Feng, Lana
    Nerenberg, Mike
    Diver, Jonathan
    Harris, Sarah
    CANCER RESEARCH, 2009, 69
  • [9] Flow cytometry minimal residual disease after allogeneic transplant for chronic lymphocytic leukemia
    Algrin, Caroline
    Golmard, Jean-Louis
    Michallet, Mauricette
    Reman, Oumedaly
    Huynh, Anne
    Perrot, Aurore
    Sirvent, Anne
    Plesa, Adriana
    Salaun, Veronique
    Bene, Marie-Christine
    Bories, Dominique
    Tournilhac, Olivier
    Merle-Beral, Helene
    Leblond, Veronique
    Le Garff-Tavernier, Magali
    Dhedin, Nathalie
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (04) : 363 - 370
  • [10] A Complementary Role of High Throughput Sequencing and Multiparameter Cytometry for Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL):an European Research Initiative (ERIC) Study
    Rawstron, Andy
    Fazi, Claudia
    Villamor, Neus
    Delgado, Julio
    Letestu, Remi
    Cymbalista, Florence
    Palacio, Carlos
    Bosch, Francesc
    De Tute, Ruth M.
    Liptrot, Stuart
    O'Brien, David
    Spacek, Martin
    Dobber, Johan
    Kater, Arnon P.
    Gambell, Peter C.
    Westerman, David A.
    Soosapilla, Asha
    Mulligan, Stephen P.
    Lozanski, Gerard
    Lin, Ke
    Pettitt, Andrew R.
    Brachtl, Gabi
    Egle, Alexander
    Williamson, David W.
    Sanders, Catherine M.
    Robins, Harlan
    Boysen, Justin
    Shanafelt, Tait D.
    Hanson, Curtis A.
    Jorgensen, Jeffrey L.
    Wierda, William G.
    Yuan, Constance
    Stetler-Stevenson, Maryalice
    Rassenti, Laura
    Broome, H. Elizabeth
    Kipps, Thomas J.
    Hauwel, Mathieu
    Marinov, Iuri
    Craig, Fiona E.
    Josep, Nomdedeu
    Moreno, Carol
    Stehlikova, Olga
    Doubek, Michael
    Pospisilova, Sarka
    Kreuzer, Karl-Anton
    Hallek, Michael
    Hillmen, Peter
    Montserrat, Emili
    Ghia, Paolo
    BLOOD, 2014, 124 (21)
12345